Biological Agents in Familial Mediterranean Fever Focusing on Colchicine Resistance and Amyloidosis | oneAMYLOIDOSISvoice
Scientific Articles

Biological Agents in Familial Mediterranean Fever Focusing on Colchicine Resistance and Amyloidosis

key information

source: Current Medicinal Chemistry

year: 2015

authors: Sozeri B, Kasapcopur O

summary/abstract:

Familial Mediterranean fever (FMF) is the most common hereditary autoinflammatory syndrome. FMF is caused by mutations in the MEFV gene which encodes the pyrin protein. FMF is characterized by sporadic, paroxysmal attacks of fever and serosal inflammation, lasting 1-3 days. Patients may develop renal amyloidosis. Colchicine prevents attacks and renal amyloidosis. 5% to 10% of the patients with FMF are resistant or intolerant to colchicine. Colchicine resistant patients may receive biological therapies. Anti-interleukin-1 drugs are the most important agents of biological treatments. In this review, colchicine resistance and treatment options will be evaluated.

organization: Istanbul University, Turkey

DOI: 10.2174/0929867322666150311152300

read more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close